At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 110 enrolled
Drug / intervention
Ibuprofen +2 moredrug
Likely dose
Ibuprofen 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase II Study of the Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients Undergoing Chemotherapy
In Brief
A Phase 2 clinical trial evaluating Ibuprofen, Home-Based Exercise, and 1 other intervention for Cancer-related Cognitive Difficulties. Completed, enrolled 110 participants across 1 site.
Detailed Summary
This research seeks to determine if a combination of low-dose ibuprofen along with a structured home-based walking and progressive resistance exercise program, EXCAP, will be effective in reducing cognitive difficulties among cancer patients receiving chemotherapy.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer-related Cognitive Difficulties
CountriesUnited States
Timeline
Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedNov 2010
Primary CompletionDec 2019
Study CompletionDec 2020
TodayJul 2026
First PostedNov 10, 2010
Enrollment StartNov 1, 2010
Primary CompletionDec 1, 2019
Study CompletionDec 1, 2020
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 15.6 years ago
Interventions
Ibuprofendrug
200 mg BID and 8 hours apart
Home-Based Exercisebehavioral
A progressive walking and resistance band exercise program called Exercise for Cancer patient (EXCAP) for a 6 week period
Placebodrug
200mg BID and 8 hours apart